Companies: 48,874 Total Market Cap: 132460447025120.92

Terumo

TYO-4543
Healthcare Medical Instruments & Supplies
Rank #767
Market Cap 27.52 B
Volume 2.39 M
Price 18.66
Change (%) 0.50%
Country or region Japan Japan

Terumo's latest marketcap:

27.52 B

As of 05/19/2025, Terumo's market capitalization has reached $27.52 B. According to our data, Terumo is the 767th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 27.52 B
Revenue (ttm) 7.15 B
Net Income (ttm) 806.91 M
Shares Out 1.47 B
EPS (ttm) 0.54
Forward PE 26.63
Ex-Dividend Date 03/28/2025
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/19/2025

Terumo's yearly market capitalization.

Terumo has seen its market value grow from ¥3.26 T to ¥3.99 T since 2020, representing a total increase of 22.46% and an annual compound growth rate (CAGR) of 4.73%.
Date Market Cap Change (%)
05/19/2025 ¥3.99 T -9.34%
12/30/2024 ¥4.52 T 31.32%
12/29/2023 ¥3.44 T 23.3%
12/30/2022 ¥2.79 T -24.11%
12/30/2021 ¥3.68 T 12.82%
12/30/2020 ¥3.26 T

Company Profile

About Terumo Corporation

Terumo Corporation is a global leader in the manufacture and sale of medical products and equipment, serving markets in Japan, Europe, China, the United States, Asia, and internationally.

Business Segments

The company operates through three key segments, each specializing in distinct medical technologies:

  • Cardiac and Vascular Company - Offers products such as:
    • Angiographic guidewires, catheters, and introducer sheaths
    • Vascular closure devices and PTCA balloon catheters
    • Coronary stents and self-expanding peripheral stents
    • Intravascular ultrasound systems and imaging catheters
    • Devices for treating cerebral aneurysms and ischemic stroke
    • Oxygenators and cardio-pulmonary bypass systems
    • Artificial vascular and stent grafts
  • Medical Care Solutions Company - Provides solutions including:
    • Syringes, infusion pumps, and I.V. solutions
    • Peritoneal dialysis fluids and nutritious food products
    • Blood glucose monitoring systems and insulin patch pumps
    • Blood pressure monitors and digital thermometers
    • Contract manufacturing for pharmaceutical companies
  • Blood and Cell Technologies Company - Specializes in:
    • Blood bags and component collection systems
    • Automated blood processing and pathogen reduction systems
    • Centrifugal apheresis and cell expansion systems

Company Background

Originally founded as Sekisen Ken-onki Corporation in 1921, the company rebranded as Terumo Corporation in October 1974. Today, it is headquartered in Tokyo, Japan, and continues to innovate in medical technology worldwide.

Frequently Asked Questions

As of 05/19/2025, Terumo (including the parent company, if applicable) has an estimated market capitalization of $27.52 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Terumo global market capitalization ranking is approximately 767 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Japan
Founded 1921
IPO Date n/a
Employees 30,591
CEO Hikaru Samejima
Sector Healthcare
Industry Medical Instruments & Supplies
Address 2-44-1, Hatagaya
Tokyo, 151-0072
Japan
Website https://www.terumo.com